1,758
Views
0
CrossRef citations to date
0
Altmetric
Epidemiology

ALS and fertility: does ALS affect number of children patients have?

ORCID Icon, , , , , , , , , & show all
Pages 94-100 | Received 26 May 2020, Accepted 17 Aug 2020, Published online: 08 Sep 2020

References

  • Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771–6.
  • Collaborators GBDMND. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1083–97.
  • Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
  • Medawar PB. The Uniqueness of the Individual. London: Methuen; 1957.
  • Longinetti E, Regodon Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi LO, et al. The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:528–37.
  • Palese F, Sartori A, Verriello L, Ros S, Passadore P, Manganotti P, et al. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002-2014: a retrospective population-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:90–9.
  • Benjaminsen E, Alstadhaug KB, Gulsvik M, Baloch FK, Odeh F. Amyotrophic lateral sclerosis in Nordland county, Norway, 2000-2015: prevalence, incidence, and clinical features. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:522–7.
  • Jun KY, Park J, Oh KW, Kim EM, Bae JS, Kim I, et al. Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry. 2019;90:395–403.
  • Turgut N, Varol SaraCoglu G, Kat S, Balci K, B GU, Birgili O, et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006-2010. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:100–6.
  • Leighton DJ, Newton J, Stephenson LJ, Colville S, Davenport R, Gorrie G, et al.; CARE-MND Consortium. Changing epidemiology of motor neurone disease in Scotland. J Neurol. 2019;266:817–25.
  • Dorst J, Chen L, Rosenbohm A, Dreyhaupt J, Hubers A, Schuster J, et al. Prognostic factors in ALS: a comparison between Germany and China. J Neurol. 2019;266:1516–25.
  • Goutman SA, Boss J, Patterson A, Mukherjee B, Batterman S, Feldman EL. High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90:907–12.
  • Ryan M, Zaldivar Vaillant T, McLaughlin RL, Doherty MA, Rooney J, Heverin M, et al. Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations. J Neurol Neurosurg Psychiatry. 2019;90:659–65.
  • Li TM, Alberman E, Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry. 1988;51:778–84.
  • Camu W, Khoris J, Moulard B, Salachas F, Briolotti V, Rouleau GA, et al. Genetics of familial ALS and consequences for diagnosis. French ALS Research Group. J Neurol Sci. 1999;165: S21–S6.
  • Pliner HA, Mann DM, Traynor BJ. Searching for Grendel: origin and global spread of the C9ORF72 repeat expansion. Acta Neuropathol. 2014;127:391–6.
  • Konno T, Shiga A, Tsujino A, Sugai A, Kato T, Kanai K, et al. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72. J Neurol Neurosurg Psychiatry. 2013;84:398–401.
  • Alavi A, Nafissi S, Rohani M, Shahidi G, Zamani B, Shamshiri H, et al. Repeat expansion in C9ORF72 is not a major cause of amyotrophic lateral sclerosis among Iranian patients. Neurobiol Aging. 2014;35:267.e1.
  • Murros K, Fogelholm R. Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand. 1983;67:41–7.
  • Karlsson EK, Kwiatkowski DP, Sabeti PC. Natural selection and infectious disease in human populations. Nat Rev Genet. 2014;15:379–93.
  • Crow JFK. Motoo. An introduction to population genetics theory. Caldwell, NJ: The Blackburn Press; 2009.
  • Carleton GD. The Transmissible Dementias and Other Brain Disorders Caused by Unconventional Viruses. In: Edouard Kurstak ZJL, P. V. Morozov, editor. Viruses, Immunity, and Mental Disorders Springer US; 1987.
  • Byrne S, Heverin M, Bede P, Elamin M, Hardiman O. Fecundity in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:204–6.
  • Johnson WG, Lucek PR, Chatkupt S, Furman Y, Lustenberger A, Lazzarini A. Reduced fecundity in male ALS gene-carriers. Am J Med Genet. 1995;59:149–53.
  • De Carvalho M, Ryczkowski A, Andersen P, Gromicho M, Grosskreutz J, Kuzma-Kozakiewicz M, et al. International survey of ALS experts about critical questions for assessing patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:505–10.
  • R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2013. Available at: http://www.R-project.org/.
  • Human Development Report 2019 [Internet]. December 12, 2019. Available at: http://www.hdr.undp.org/en.
  • Henderson RD, Garton FC, Kiernan MC, Turner MR, Eisen A. Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90:570–5.
  • Ying W. A new hypothesis of neurodegenerative diseases: the deleterious network hypothesis. Med Hypotheses. 1996;47:307–13.
  • Ruhli FJ, Henneberg M. New perspectives on evolutionary medicine: the relevance of microevolution for human health and disease. BMC Med. 2013;11:115.
  • Arthur KC, Calvo A, Price TR, Geiger JT, Chio A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.